Optimal treatment sequencing of abiraterone acetate plus prednisone and enzalutamide in patients with castration-resistant metastatic prostate cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Optimal treatment sequencing of abiraterone acetate plus prednisone and enzalutamide in patients with castration-resistant metastatic prostate cancer: A systematic review and meta-analysis

Published:2021-02 Issue: Volume:93 Page:102152
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Cassinello J.,Domínguez-Lubillo T.,Gómez-Barrera M.,Hernando T.,Parra R.,Asensio I.,Casado M.A.,Moreno P.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference58 articles.

1. Epidemiology of Prostate Cancer;Rawla;World J Oncol,2019

2. Prostate cancer in elderly men;Stangelberger;Rev Urol,2008

3. Steps in prostate cancer progression that lead to bone metastasis;Jin;Int J Cancer,2011

4. A population-based study of progression to metastatic prostate cancer in Australia;Luo;Cancer Epidemiol,2015

5. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality;Scosyrev;Cancer,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of adherence to abiraterone therapy in prostate cancer patients based on a population pharmacokinetic model;British Journal of Clinical Pharmacology;2024-07-03

2. Real-world outcomes for first line next-generation hormonal agents in metastatic prostate cancer: a systematic review;Future Oncology;2023-11

3. Steroidal alkaloids from the roots of Veratrum stenophyllum;Fitoterapia;2023-04

4. Real-World Cabazitaxel Use and Outcomes in Metastatic Castrate-Resistant Prostate Cancer: The Impact of Response to First ARPI;Clinical Genitourinary Cancer;2022-10